Group One Trading’s Roivant Sciences ROIV Stock Holding History

Group One Trading’s Portfolio ROIV Stock Details ROIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.75M	Buy	77,622 +38,350	+98%	+$1.13M	﹤0.01%	1930
2026 Q1	$1.09M	Buy	+39,272	New	+$1.01M	﹤0.01%	2628
2025 Q3	–	Sell	-37,316	Closed	-$462K	–	9044
2025 Q2	$421K	Buy	37,316 +36,101	+2,971%	+$391K	﹤0.01%	3591
2025 Q1	$12.3K	Buy	+1,215	New	+$13.1K	﹤0.01%	6123
2024 Q3	–	Sell	-44,604	Closed	-$508K	–	7265
2024 Q2	$471K	Sell	44,604 -5,064	-10%	-$55.5K	﹤0.01%	2612
2024 Q1	$524K	Buy	+49,668	New	+$536K	﹤0.01%	2683
2023 Q4	–	Sell	-71,687	Closed	-$699K	–	8081
2023 Q3	$837K	Buy	71,687 +53,413	+292%	+$604K	﹤0.01%	2436
2023 Q2	$184K	Buy	+18,274	New	+$163K	﹤0.01%	4021
2022 Q4	–	Sell	-11,100	Closed	-$61.7K	–	7973
2022 Q3	$36K	Buy	+11,100	New	+$43K	﹤0.01%	5664

Other funds holding ROIV

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Group One Trading's ROIV Position: Q2 2026 in Review

Group One Trading increased its Roivant Sciences (ROIV) stake by 98% in Q2 2026, buying an estimated $1.13M and bringing the position to 77,622 shares worth $2.75M. The position accounts for ﹤0.01% of the portfolio, ranked #1930.

Group One Trading first reported a position in ROIV in Q3 2022 and has held it in 9 quarters since. 500 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

Group One Trading held 77,622 shares of Roivant Sciences worth $2.75M as of Q2 2026.
Group One Trading bought 38,350 Roivant Sciences shares in Q2 2026, an estimated $1.13M.
Roivant Sciences made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #1930 holding.
Group One Trading first reported a position in Roivant Sciences in Q3 2022 and has held it in 9 quarters since.
500 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.